Table_1_18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment.docx

Table_1_18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment.docx

Background<p>The aim of this study was to evaluate <sup>18</sup>F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography (<sup>18</sup>F-RGD PET/CT) and serum inflammation biomarkers for predicting outcomes of patients receiving combined antiangiogenic treatmen...

Full description

Saved in:
Bibliographic Details
Main Author: Jie Liu (15128) (author)
Other Authors: Leilei Wu (2363809) (author), Zhiguo Liu (594653) (author), Samuel Seery (9021539) (author), Jianing Li (359834) (author), Zhenhua Gao (501522) (author), Jinming Yu (652099) (author), Xue Meng (780252) (author)
Published: 2021
Subjects:
Cancer
Cancer Cell Biology
Cancer Diagnosis
Cancer Genetics
Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
Chemotherapy
Haematological Tumours
Molecular Targets
Radiation Therapy
Solid Tumours
Oncology and Carcinogenesis not elsewhere classified
18F-RGD PET/CT
inflammatory biomarkers
outcome prediction
combined antiangiogenic therapy
NSCLC
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items